Critical factors determining dimerization of human antizyme inhibitor.
about
Antizyme inhibitor 1: a potential carcinogenic moleculeStructural and degradative aspects of ornithine decarboxylase antizyme inhibitor 2.Model-enabled gene search (MEGS) allows fast and direct discovery of enzymatic and transport gene functions in the marine bacterium Vibrio fischeri.Novel interaction of ornithine decarboxylase with sepiapterin reductase regulates neuroblastoma cell proliferation.Critical factors governing the difference in antizyme-binding affinities between human ornithine decarboxylase and antizyme inhibitor.Minimal antizyme peptide fully functioning in the binding and inhibition of ornithine decarboxylase and antizyme inhibitor.Functional roles of the dimer-interface residues in human ornithine decarboxylase.Determinants of the differential antizyme-binding affinity of ornithine decarboxylaseDiscovery of novel inhibitors of human S-adenosylmethionine decarboxylase based on in silico high-throughput screening and a non-radioactive enzymatic assay.Control of Polyamine Biosynthesis by Antizyme Inhibitor 1 Is Important for Transcriptional Regulation of Arginine Vasopressin in the Male Rat Hypothalamus.Multifaceted interactions and regulation between antizyme and its interacting proteins cyclin D1, ornithine decarboxylase and antizyme inhibitor.Current status of the polyamine research fieldActivation of polyamine catabolic enzymes involved in diverse responses against epibrassinolide-induced apoptosis in LNCaP and DU145 prostate cancer cell lines.Characterization of an androgen-responsive, ornithine decarboxylase-related protein in mouse kidney.
P2860
Q28074076-073F992B-0080-4607-BEF0-29227DF4E4C8Q29347303-FBF7598C-294A-4096-B859-EF148ADF6290Q30030541-15553E50-8A75-47DB-ADC2-000FACB89C68Q33578405-9BF3DDD5-FC29-4320-BBD5-5EA21F6C6870Q33892549-DCD5FBE9-8CA1-4C04-882B-8F9BD3FB8BB6Q34023433-36791751-8459-4435-9545-A96F6486041FQ34070766-8EEE4C59-0B54-4103-A884-B88CEB140554Q34071636-0F470EA3-26FE-4B9A-B8C0-1FE2EAF45AF7Q35648294-C06D0B0A-2177-499D-9F94-D25CFE58BEDBQ35878827-7DDF1924-6957-4032-8C93-89D796FE4605Q36414339-ECCD6F36-9AC7-43F6-9B25-52AD7D9D465EQ36838564-C95E3338-BF08-45D1-8A71-6A9628AC1C85Q39107457-D0B38C4E-718A-4966-89F8-21677AE26C36Q42334823-DFD1DDD9-4CA5-474C-87A3-496DEFE58C6C
P2860
Critical factors determining dimerization of human antizyme inhibitor.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Critical factors determining dimerization of human antizyme inhibitor.
@en
Critical factors determining dimerization of human antizyme inhibitor.
@nl
type
label
Critical factors determining dimerization of human antizyme inhibitor.
@en
Critical factors determining dimerization of human antizyme inhibitor.
@nl
prefLabel
Critical factors determining dimerization of human antizyme inhibitor.
@en
Critical factors determining dimerization of human antizyme inhibitor.
@nl
P2093
P2860
P356
P1476
Critical factors determining dimerization of human antizyme inhibitor
@en
P2093
Guang-Yaw Liu
Kuo-Liang Su
Ya-Fan Liao
P2860
P304
26768-26777
P356
10.1074/JBC.M109.007807
P407
P577
2009-07-27T00:00:00Z